These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2621583)

  • 1. Spherical agglomerates of water-insoluble drugs.
    Bodmeier R; Paeratakul O
    J Pharm Sci; 1989 Nov; 78(11):964-7. PubMed ID: 2621583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach to the oral delivery of micro- or nanoparticles.
    Bodmeier R; Chen HG; Paeratakul O
    Pharm Res; 1989 May; 6(5):413-7. PubMed ID: 2748533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release characteristics of chitosan treated alginate beads: II. Sustained release of a low molecular drug from chitosan treated alginate beads.
    Sezer AD; Akbuğa J
    J Microencapsul; 1999; 16(6):687-96. PubMed ID: 10575621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immobilization of lipase using hydrophilic polymers in the form of hydrogel beads.
    Betigeri SS; Neau SH
    Biomaterials; 2002 Sep; 23(17):3627-36. PubMed ID: 12109688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical characteristics and release behavior of salbutamol sulfate beads prepared with different ionic polysaccharides.
    el Fattah EA; Grant DJ; Gabr KE; Meshali MM
    Drug Dev Ind Pharm; 1998 Jun; 24(6):541-7. PubMed ID: 9876620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of melatonin-loaded stearyl alcohol microspheres.
    Lee BJ; Choe JS; Kim CK
    J Microencapsul; 1998; 15(6):775-87. PubMed ID: 9818955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone.
    Wittaya-areekul S; Kruenate J; Prahsarn C
    Int J Pharm; 2006 Apr; 312(1-2):113-8. PubMed ID: 16490331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization.
    Sankalia MG; Mashru RC; Sankalia JM; Sutariya VB
    Eur J Pharm Biopharm; 2007 Feb; 65(2):215-32. PubMed ID: 16982178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    AAPS PharmSciTech; 2007 Aug; 8(3):E64. PubMed ID: 17915814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle design of tolbutamide by the spherical crystallization technique. III. Micromeritic properties and dissolution rate of tolbutamide spherical agglomerates prepared by the quasi-emulsion solvent diffusion method and the solvent change method.
    Sano A; Kuriki T; Kawashima Y; Takeuchi H; Hino T; Niwa T
    Chem Pharm Bull (Tokyo); 1990 Mar; 38(3):733-9. PubMed ID: 2347016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
    Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
    Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microencapsulation of drugs with aqueous colloidal polymer dispersions.
    Bodmeier R; Wang J
    J Pharm Sci; 1993 Feb; 82(2):191-4. PubMed ID: 8445534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan matrix for oral sustained delivery of ampicillin.
    Chandy T; Sharma CP
    Biomaterials; 1993 Oct; 14(12):939-44. PubMed ID: 8268386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gelation conditions and dissolution media on the release of paracetamol from alginate gel beads.
    Aslani P; Kennedy RA
    J Microencapsul; 1996; 13(5):601-14. PubMed ID: 8864996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-unit floating alginate system: effect of additives on ciprofloxacin release.
    Srinatha A; Pandit JK
    Drug Deliv; 2008 Sep; 15(7):471-6. PubMed ID: 18712625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
    Nurulaini H; Wong TW
    J Pharm Sci; 2011 Jun; 100(6):2248-57. PubMed ID: 21213311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counter-intuitive enhancement in the dissolution of indomethacin with the incorporation of cohesive poorly water-soluble inorganic salt additives.
    Tay T; Allahham A; Morton DA; Stewart PJ
    Eur J Pharm Biopharm; 2011 Nov; 79(3):674-82. PubMed ID: 21703348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microspheres of alginate-chitosan containing isoniazid.
    Lucinda-Silva RM; Evangelista RC
    J Microencapsul; 2003; 20(2):145-52. PubMed ID: 12554370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the drug-polymer interaction in calcium alginate beads containing diflunisal.
    Mandal B; Alexander KS; Riga AT
    Pharmazie; 2010 Feb; 65(2):106-9. PubMed ID: 20225653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.